Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v16-EN
Language French English
Date Updated 2022-04-13 2022-06-08
Drug Identification Number 02433087 02433087
Brand name MOXIFLOXACIN INJECTION MOXIFLOXACIN INJECTION
Common or Proper name Moxifloxacin Injection 1.6 mg/mL freeflex® Bag 250 mL Moxifloxacin Injection 1.6 mg/mL freeflex® Bag 250 mL
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients MOXIFLOXACIN MOXIFLOXACIN
Strength(s) 400MG 400MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 250 mL 250 mL
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-10-05 2021-10-05
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status Yes Yes
Company comments On 100% allocation. On 200% allocation.
Health Canada comments